Cell Signalling and Disease 4D option BIOL4027
- Academic Session: 2019-20
- School: School of Life Sciences
- Credits: 20
- Level: Level 4 (SCQF level 10)
- Typically Offered: Semester 2
- Available to Visiting Students: Yes
- Available to Erasmus Students: Yes
This course will examine the three fundamental components of drug action: the molecular trigger (receptors), intracellular signalling, and physiological responses. The course will consider how these processes might be targeted in the treatment of a variety of human diseases.
This option is assigned to block S2-D. There is normally 3-hours of teaching on Fridays.
Requirements of Entry
Normally, only available to final-year School of Life Sciences students in a Degree Group B (Biomolecular Sciences group) or Degree Group C (Human Life Sciences group) programme. Visiting students may be allowed to enrol, at the discretion of the School of Life Sciences Chief Adviser and the Course Coordinator.
The course will be assessed by a 2-hour examination (75%) and in-course assessment consisting of a critical analysis of scientific data (25%).
Main Assessment In: April/May
Are reassessment opportunities available for all summative assessments? Not applicable for Honours courses
Reassessments are normally available for all courses, except those which contribute to the Honours classification. For non Honours courses, students are offered reassessment in all or any of the components of assessment if the satisfactory (threshold) grade for the overall course is not achieved at the first attempt. This is normally grade D3 for undergraduate students and grade C3 for postgraduate students. Exceptionally it may not be possible to offer reassessment of some coursework items, in which case the mark achieved at the first attempt will be counted towards the final course grade. Any such exceptions for this course are described below.
This course aims to apply fundamental aspects of receptor biology and signal transduction to the targeting of key physiological pathways for the treatment of human diseases.
Intended Learning Outcomes of Course
By the end of this course, students will be able to:
■ Discuss G-protein coupled receptor pharmacology;
■ Relate signal transduction pathways to normal physiology and disease;
■ Discuss how to validate a molecular target in disease treatment;
■ Relate novel technologies and animal disease models with different drug targeting approaches;
■ Discuss novel ways of targeting G-protein coupled receptors, phosphodiesterases, protein kinases and enzymes of the ubiquitylation system.
Minimum Requirement for Award of Credits
Students must submit at least 75% by weight of the components (including examinations) of the course's summative assessment.